UK pharma company Martindale Pharma has announced the appointment of AFT Pharmaceuticals as its distribution partner for several Asia Pacific markets.
AFT has a significant presence in Asia Pacific and operates across New Zealand, Australia, Malaysia, Hong Kong, Singapore and Brunei. Under this new agreement, AFT Pharmaceuticals will be responsible for the registration, distribution, promotion and marketing of certain of Martindale Pharma’s products in Malaysia, Singapore and Brunei.
Mike Harris, Martindale Pharma chief executive, said: “The demand for Critical Care and Hospital Specialty products in these markets is growing rapidly. Martindale Pharma’s strategy is to partner with companies that have a strong presence in key international markets. We look forward to working with AFT Pharmaceuticals to distribute and promote world-class products to patients and hospitals in Malaysia, Singapore and Brunei.”
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze